Greenlight Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-206,418
Closed -$3.67M 50
2014
Q3
$3.67M Sell
206,418
-185,957
-47% -$3.8M 0.05% 47
2014
Q2
$9.42M Sell
392,375
-1,050,533
-73% -$21.3M 0.13% 39
2014
Q1
$36.3M Sell
1,442,908
-868,680
-38% -$24M 0.54% 32
2013
Q4
$51M Buy
2,311,588
+33,859
+1% +$684K 0.7% 30
2013
Q3
$48.6M Buy
+2,277,729
New +$52.6M 0.8% 27

Other funds holding PGEN

Greenlight Capital's PGEN Position: Q4 2014 in Review

Greenlight Capital sold out of Precigen (PGEN) in Q4 2014, closing a stake of 206,418 shares — an estimated $3.67M sold.

Greenlight Capital first reported a position in PGEN in Q3 2013 and held it in 5 quarters. The position peaked at $51M in Q4 2013. 108 funds tracked by Wall St. Rank hold PGEN as of Q4 2014.

  • Greenlight Capital reported no remaining Precigen position as of Q4 2014 after selling out during the quarter.
  • Greenlight Capital sold 206,418 Precigen shares in Q4 2014, an estimated $3.67M.
  • Greenlight Capital first reported a position in Precigen in Q3 2013 and held it in 5 quarters.
  • Greenlight Capital's Precigen position peaked at $51M in Q4 2013.
  • 108 funds tracked by Wall St. Rank held Precigen as of Q4 2014.

Based on Greenlight Capital's 13F filing for Q4 2014, filed 13 Feb 2015.